<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR146">
 <label>146.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Aprile</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Ferrari</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Cremolini</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Bergamo</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Fontanella</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Battaglin</surname>
    <given-names>F</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies</article-title>
  <source>Expert Rev Clin Pharmacol</source>
  <year>2016</year>
  <volume>9</volume>
  <fpage>877</fpage>
  <lpage>885</lpage>
  <pub-id pub-id-type="doi">10.1080/17512433.2016.1182861</pub-id>
  <?supplied-pmid 27149032?>
  <pub-id pub-id-type="pmid">27149032</pub-id>
 </element-citation>
</ref>
